-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Thermo Fisher Scientific (TMO)
-
-
-
-
-
-
-
Verastem Oncology prices $250M stock and warrant offering
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on LB Pharmaceuticals Inc (LBRX)
-
-
-
-
-
-
-
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Enliven Therapeutics (ELVN)
-
-
-
-
-
-
-
DraftKings Inc. (DKNG) PT Lowered to $30 at Guggenheim
-
-
-
-
-
-
-
Vaxcyte launches $1B in dual public offerings of stock and notes
-
23,828 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


